Goserelin

Goserelin Brand names, Goserelin Analogs

Goserelin Brand Names Mixture

Fluoracaine Oph Soln (Fluorescein Sodium + Proxymetacain Hcl)
Fluorescein Sodium & Benoxinate Hydrochloride Ophtalmic Solution, Usp (Benoxinate Hydrochloride + Fluorescein Sodium)
Fluress (Benoxinate Hydrochloride + Fluorescein Sodium)
Fluress Liq Oph (Benoxinate Hydrochloride + Fluorescein Sodium)

Goserelin Chemical_Formula

C₅₉H₈₄N₁₈O₁₄

Goserelin RX_link

http://www.rxlist.com/cgi/generic/goserel.htm

Goserelin fda sheet

Goserelin FDA

Goserelin msds (material safety sheet)

Goserelin Synthesis Reference

Weber et al., U.S. Pat. 3,454,635 (1969)

Goserelin Molecular Weight

1269.41 g/mol

Goserelin Melting Point

No information avaliable

Goserelin H₂O Solubility

Soluble

Goserelin State

Solid

Goserelin LogP

-2.517

Goserelin Dosage Forms

Supplied as a sterile and totally biodegradable d,l-lactic and glycolic acids copolymer (13.3-14.3 mg/dose) impregnated with goserelin acetate equivalent to 3.6 mg of goserelin in a disposable syringe device fitted with a 16-gauge hypodermic needle

Goserelin Indication

Breast cancer; Prostate carcinoma; Endometriosis

Goserelin Pharmacology

The pharmacokinetics of ZOLADEX have been determined in both male and female healthy volunteers and patients. In these studies, ZOLADEX was administered as a single 250µg (aqueous solution) dose and as a single or multiple 3.6 mg depot dose by subcutaneous route.

Goserelin Absorption

Inactive orally, rapidly absorbed following subcutaneous administration

Goserelin side effects and Toxicity

No experience of overdosage from clinical trials

Goserelin Patient Information

BIOD00113.html

Goserelin Organisms Affected

Humans and other mammals